(Q33511437)
Statements
Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10) (English)
Tong Shen
Ye-Hong Kuang
Charles R Ashby
Yu Lei
Angel Chen
Ying Zhou
Xiang Chen
Elizabeth Hopper-Borge
Jiangyong Ouyang
Zhe-Sheng Chen
20 October 2009
20 October 2009
1 reference
1 reference